Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1159, 2007-01, pp. : 30-31
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Natalizumab: First report of hypereosinophilia and erosive dermatitis: case report
Reactions Weekly, Vol. 1, Iss. 1252, 2009-01 ,pp. :
Access to resources
Recommend
Mepolizumab shows potential in hypereosinophilia
Inpharma, Vol. 1, Iss. 1630-1631, 2008-01 ,pp. :
Interferon Treatment in Patients with Hypereosinophilia
Current Drug Targets, Vol. 12, Iss. 3, 2011-03 ,pp. :
Zafirlukast labelling revised in the US
Inpharma, Vol. 1, Iss. 1256, 2000-01 ,pp. :